What are the precautions to take while using Ritlecitinib?

Ritlecitinib is a JAK3/TEC family kinase inhibitor mainly used to treat autoimmune diseases such as alopecia areata. During the use of ritexitinib, patients need to follow the doctor's instructions and pay attention to a series of safety precautions during medication. Although this drug has shown good clinical efficacy, as an immunomodulatory drug, its use must be done with extreme caution.

Ritexitinib may affect the patient's immune system, so a comprehensive physical examination should be performed before use, including liver and kidney function, blood routine, infection screening, etc. If the patient has been infected with hepatitis B, tuberculosis or other chronic infectious diseases, he or she needs to be evaluated by a doctor before deciding whether to use this drug. In addition, it is also recommended to receive necessary vaccinations, such as influenza vaccine or shingles vaccine, before taking the medication to reduce the risk of infection.

During use, physical reactions need to be closely monitored, especially if symptoms such as fever, cough, persistent fatigue, rash, etc. occur, which may indicate potential infection or allergic reaction. Once these problems occur, you should seek medical treatment promptly. Some patients may also experience an increase in blood lipids, liver enzymes or creatine kinase while taking ritexitinib. Therefore, relevant indicators should be reviewed regularly. Doctors will evaluate whether the dose needs to be adjusted or the medication needs to be suspended based on the test results.

It should be noted that ritexitinib may interact with other drugs, especially when used concurrently with immunosuppressants, antifungals, or certain antibiotics, which may affect efficacy or increase the risk of adverse reactions. Therefore, drugs should not be added or changed without authorization during use of this drug, and all treatment adjustments should be made after evaluation by a professional physician. Correct use of ritixitinib can help improve efficacy and reduce the risk of adverse reactions.

Reference materials:https://www.litfulo.com/